Osaic Holdings
OKYO

Osaic Holdings’s OKYO Pharma OKYO Stock Holding History

Osaic Holdings’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228 Hold
152
– – ﹤0.01% 7763
2026
Q1 		$244 Hold
152
– – ﹤0.01% 7536
2025
Q4 		$314 Hold
152
– – ﹤0.01% 7514
2025
Q3 		$304 Buy
+152
New +$387 ﹤0.01% 7637

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Osaic Holdings's OKYO Position: Q2 2026 in Review

Osaic Holdings held its OKYO Pharma (OKYO) position steady in Q2 2026 at 152 shares worth $228. The position accounts for ﹤0.01% of the portfolio, ranked #7763.

Osaic Holdings first reported a position in OKYO in Q3 2025 and has held it in 4 quarters since. The position peaked at $314 in Q4 2025. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Osaic Holdings held 152 shares of OKYO Pharma worth $228 as of Q2 2026.
  • Osaic Holdings left its OKYO Pharma share count unchanged in Q2 2026.
  • OKYO Pharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7763 holding.
  • Osaic Holdings first reported a position in OKYO Pharma in Q3 2025 and has held it in 4 quarters since.
  • Osaic Holdings's OKYO Pharma position peaked at $314 in Q4 2025.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.